| Hhsc - Kauai Region Clinics The Clinic At Kapaa | |
|
4800 Kawaihau Rd Kapaa HI 96746-1971 | |
| (808) 823-4157 | |
| (808) 823-4161 |
| Full Name | Hhsc - Kauai Region Clinics The Clinic At Kapaa |
|---|---|
| Speciality | Clinic/Center |
| Location | 4800 Kawaihau Rd, Kapaa, Hawaii |
| Authorized Official Name and Position | Christine Marie Asato (REGIONAL CFO) |
| Authorized Official Contact | 8083389407 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Hhsc - Kauai Region Clinics The Clinic At Kapaa Po Box 337 Waimea HI 96796-0337 Ph: (808) 338-9431 | Hhsc - Kauai Region Clinics The Clinic At Kapaa 4800 Kawaihau Rd Kapaa HI 96746-1971 Ph: (808) 823-4157 |
| NPI Number | 1508452756 |
|---|---|
| Provider Enumeration Date | 12/11/2020 |
| Last Update Date | 05/01/2024 |
| Medicare PECOS PAC ID | 1759271216 |
|---|---|
| Medicare Enrollment ID | O20210204001836 |
News Archive
Kaiser Health News staff writer Christopher Weaver writes: "The federal agency that oversees Medicaid confirmed Thursday that some money states receive as rebates from drugmakers will now be redirected to the federal government to help pay for the new health overhaul" (Weaver, 4/22).
The Food and Drug Administration (FDA) in the United States has ordered drugmakers to alert patients to the possible cardiovascular and psychiatric risks attached to drugs used to treat attention deficit hyperactivity disorder (ADHD).
A team of Cornell University scientists from the College of Veterinary Medicine, Weill Cornell Medical College and the College of Agriculture and Life Sciences have discovered that a novel group of E. coli bacteria, containing genes similar to those described in uropathogenic and avian pathogenic E. coli and enteropathogenic bacteria such as salmonella, cholera, bubonic plague, is associated with intestinal inflammation in patients with Crohn's disease in their research paper published July 12 by the ISME Journal: Multidisciplinary Journal of Microbial Ecology.
Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced the presentation of a poster at the annual American Society of Hematology (ASH) meeting that describes the preclinical activity of Arno's drug candidate AR-42 against leukemia stem cells (LSCs).
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508452756 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (* (Not Available)) | Secondary |
| 261QR1300X | Clinic/center - Rural Health | (* (Not Available)) | Primary |
News Archive
Kaiser Health News staff writer Christopher Weaver writes: "The federal agency that oversees Medicaid confirmed Thursday that some money states receive as rebates from drugmakers will now be redirected to the federal government to help pay for the new health overhaul" (Weaver, 4/22).
The Food and Drug Administration (FDA) in the United States has ordered drugmakers to alert patients to the possible cardiovascular and psychiatric risks attached to drugs used to treat attention deficit hyperactivity disorder (ADHD).
A team of Cornell University scientists from the College of Veterinary Medicine, Weill Cornell Medical College and the College of Agriculture and Life Sciences have discovered that a novel group of E. coli bacteria, containing genes similar to those described in uropathogenic and avian pathogenic E. coli and enteropathogenic bacteria such as salmonella, cholera, bubonic plague, is associated with intestinal inflammation in patients with Crohn's disease in their research paper published July 12 by the ISME Journal: Multidisciplinary Journal of Microbial Ecology.
Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced the presentation of a poster at the annual American Society of Hematology (ASH) meeting that describes the preclinical activity of Arno's drug candidate AR-42 against leukemia stem cells (LSCs).
› Verified 2 days ago
Lee A. Evslin, M.d. Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4-1558 Kuhio Hwy, Kapaa, HI 96746 Phone: 808-822-4844 Fax: 808-821-2922 | |
Paul T Esaki Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4-1461 Kuhio Hwy, Kapaa, HI 96746 Phone: 808-822-4333 Fax: 808-822-0938 | |
Kauai Holistic Medicine Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4504 Kukui St, Suite 13, Kapaa, HI 96746 Phone: 808-823-0994 Fax: 808-823-0995 | |
Lisa S Splittstoesser Md Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4-1558 Kuhio Hwy, Kapaa, HI 96746 Phone: 808-822-4844 Fax: 808-821-2922 | |
Wailua Wellness Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 285 Kamokila Rd, Kapaa, HI 96746 Phone: 732-278-6608 | |
Hhsc - Kauai Region Clinics The Clinic At Kapaa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4800 Kawaihau Rd, Kapaa, HI 96746 Phone: 808-332-8523 Fax: 808-332-7050 |